Header cover image

Japanese (NIKKEI) Clinical Research and Equipment Industry Analysis

UpdatedApr 17, 2025
DataAggregated Company Financials
Companies14
  • 7D1.6%
  • 3M-17.6%
  • 1Y-26.2%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 1.6%, with WDB coco up 7.1%. Meanwhile, Shin Nippon Biomedical Laboratories actually underperformed within the industry, shrinking 11% in the last week. In contrast, the industry has lost 26% in the last 12 months. As for the next few years, earnings are expected to grow by 16% per annum.

Industry Valuation and Performance

Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 17 Apr 2025JP¥128.2bJP¥63.8bJP¥963.0m13.8x133.2x2x
Sat, 15 Mar 2025JP¥162.8bJP¥64.8bJP¥927.9m15.5x175.4x2.5x
Mon, 10 Feb 2025JP¥173.8bJP¥66.0bJP¥1.6b15.9x109.8x2.6x
Wed, 08 Jan 2025JP¥165.4bJP¥62.0bJP¥440.7m17.7x375.4x2.7x
Fri, 06 Dec 2024JP¥163.0bJP¥62.0bJP¥825.9m16.8x197.4x2.6x
Sun, 03 Nov 2024JP¥149.8bJP¥61.5bJP¥1.8b21.2x81.3x2.4x
Tue, 01 Oct 2024JP¥152.3bJP¥61.5bJP¥1.8b17.6x82.7x2.5x
Thu, 29 Aug 2024JP¥167.3bJP¥61.5bJP¥2.1b20.2x79.3x2.7x
Sat, 27 Jul 2024JP¥162.5bJP¥61.8bJP¥3.2b24.9x50.2x2.6x
Mon, 24 Jun 2024JP¥162.9bJP¥61.8bJP¥3.2b26x50.3x2.6x
Wed, 22 May 2024JP¥165.4bJP¥61.8bJP¥3.4b25.3x48.5x2.7x
Fri, 19 Apr 2024JP¥181.7bJP¥62.3bJP¥3.3b14.3x55.2x2.9x
Sun, 17 Mar 2024JP¥227.6bJP¥155.4bJP¥8.6b13.8x26.4x1.5x
Tue, 13 Feb 2024JP¥232.8bJP¥156.2bJP¥9.0b14.6x25.8x1.5x
Thu, 11 Jan 2024JP¥233.6bJP¥167.1bJP¥8.5b15.8x27.5x1.4x
Sat, 09 Dec 2023JP¥227.6bJP¥167.4bJP¥8.7b14.5x26.2x1.4x
Mon, 06 Nov 2023JP¥225.7bJP¥179.4bJP¥12.9b14.3x17.5x1.3x
Wed, 04 Oct 2023JP¥248.2bJP¥179.3bJP¥12.8b15.3x19.4x1.4x
Fri, 01 Sep 2023JP¥269.5bJP¥179.3bJP¥12.8b17.1x21.1x1.5x
Sun, 30 Jul 2023JP¥268.7bJP¥178.7bJP¥15.7b16.1x17.2x1.5x
Tue, 27 Jun 2023JP¥283.9bJP¥178.5bJP¥16.2b17.5x17.5x1.6x
Thu, 25 May 2023JP¥278.7bJP¥178.2bJP¥15.9b15.7x17.5x1.6x
Sat, 22 Apr 2023JP¥285.5bJP¥171.9bJP¥13.3b16.5x21.5x1.7x
Mon, 20 Mar 2023JP¥318.6bJP¥171.9bJP¥13.3b16.6x24x1.9x
Wed, 15 Feb 2023JP¥301.9bJP¥171.3bJP¥13.1b16.7x23.1x1.8x
Fri, 13 Jan 2023JP¥294.5bJP¥166.1bJP¥16.2b14.6x18.2x1.8x
Sun, 11 Dec 2022JP¥318.1bJP¥165.5bJP¥16.0b14.7x19.9x1.9x
Tue, 08 Nov 2022JP¥313.6bJP¥161.3bJP¥13.2b16.3x23.8x1.9x
Thu, 06 Oct 2022JP¥326.3bJP¥160.1bJP¥12.4b17.1x26.4x2x
Sat, 03 Sep 2022JP¥311.4bJP¥159.7bJP¥12.3b18.9x25.4x2x
Mon, 01 Aug 2022JP¥304.7bJP¥159.9bJP¥12.7b18.6x24x1.9x
Wed, 29 Jun 2022JP¥284.7bJP¥152.8bJP¥10.9b17.1x26.1x1.9x
Fri, 27 May 2022JP¥241.9bJP¥152.7bJP¥10.9b17.8x22.2x1.6x
Sun, 24 Apr 2022JP¥247.7bJP¥144.9bJP¥10.6b20.2x23.3x1.7x
Price to Earnings Ratio

23.3x


Total Market Cap: JP¥247.7bTotal Earnings: JP¥10.6bTotal Revenue: JP¥144.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Clinical Research and Equipment Industry Price to Earnings3Y Average 60.9x202320242025
Current Industry PE
  • Investors are optimistic on the Japanese Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 133x which is higher than its 3-year average PE of 60.9x.
  • The industry is trading close to its 3-year average PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have declined 55% per year over the last three years,
  • Revenues have also declined 24% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Comparison

How does Japanese Clinical Research and Equipment compare with similar industries?

JP Market6.32%
Healthcare3.88%
Life Sciences1.64%
Clinical Research and Equipment1.64%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
7079 WDB cocoJP¥3.26k7.1%
+JP¥517.0m
-28.0%PE8.3x
2370 MEDINETJP¥32.003.2%
+JP¥264.7m
-31.9%n/a
4241 atectJP¥396.008.5%
+JP¥137.0m
-43.6%PS0.6x
4583 Chiome BioscienceJP¥128.001.6%
+JP¥135.5m
-1.5%PS11.1x
4572 Carna BiosciencesJP¥254.002.8%
+JP¥133.7m
-43.6%PS7.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

2370

JP¥32.00

MEDINET

7D

3.2%

1Y

-31.9%

2397

JP¥1,085.00

DNA Chip Research

7D

-1.3%

1Y

-13.3%

7079

JP¥3,260.00

WDB coco

7D

7.1%

1Y

-28.0%

4570

JP¥447.00

Immuno-Biological Laboratories

7D

2.5%

1Y

-1.1%

2183

JP¥290.00

Linical

7D

1.4%

1Y

-27.3%

4241

JP¥396.00

atect

7D

8.5%

1Y

-43.6%

4572

JP¥254.00

Carna Biosciences

7D

2.8%

1Y

-43.6%

4583

JP¥128.00

Chiome Bioscience

7D

1.6%

1Y

-1.5%

4892

JP¥985.00

Cyfuse Biomedical K.K

7D

-0.4%

1Y

41.1%